Indication
Anthelmintic Agent
1 clinical trial
2 products
Product
IvermectinProduct
StromectolClinical trial
Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting ConditionsStatus: Completed, Estimated PCD: 2020-12-21